Friday, July 31, 2026

Penetrium’s Innovative Cancer Drug Enters Phase 2 Trials in the U.S.: What You Need to Know

Penetrium Bioscience is submitting an IND for Penetrium to start Phase 2 cancer trials in the U.S., leveraging prior safety data.

RIA Accounts Hit 1 Trillion KRW: What This Means for Korean Investors

RIA accounts in Korea have attracted over 1 trillion KRW in a month, boosting domestic investment with tax incentives for investors.

North Korea Conducts Hypersonic Missile Drill… Kim Jong-un Vows To Maintain And Expand Nuclear Deterrence

North Korea launched a hypersonic missile, with Kim Jong-un personally overseeing the launch, according to state media reports.

Tag: commitment

No posts to display

Top News

- Our Sponsors Ad -

Follow us